Unknown

Dataset Information

0

[CMP] [cell line] [SIDM01667] Mantle Cell Lymphoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO1667 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
| S-EPMC8556305 | biostudies-literature
Unknown Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
| S-EPMC4741926 | biostudies-literature
Unknown Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.
| S-EPMC8718245 | biostudies-literature
Unknown First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation.
| S-EPMC9130771 | biostudies-literature
Unknown Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, Arbo.
| S-EPMC9713070 | biostudies-literature
Unknown Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study.
| S-EPMC7000480 | biostudies-literature
Unknown Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
| S-EPMC10912842 | biostudies-literature
Unknown Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
| S-EPMC12927045 | biostudies-literature
Unknown MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
| S-EPMC8654320 | biostudies-literature
Unknown Emerging therapies in mantle cell lymphoma.
| S-EPMC7302387 | biostudies-literature